ANI Pharmaceuticals, Inc. (ANIP) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Ani Pharmaceuticals, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.000 -- 00:00:05.000 Good day, everyone, and welcome to today's ANI Pharmaceuticals 00:00:05.000 -- 00:00:09.880 Inc. 2Q 2025 Earnings Results Call. 00:00:09.880 -- 00:00:13.320 Please note, this call is being recorded. 00:00:13.320 -- 00:00:19.140 After the speaker's opening remarks, there will be a question and answer session. 00:00:19.140 -- 00:00:24.140 If you would like to ask a question during this time, simply press star, then 00:00:24.140 -- 00:00:27.080 the number one on your telephone keypad. 00:00:27.080 -- 00:00:32.300 If you would like to withdraw your question, please press the star key, 00:00:32.300 -- 00:00:36.000 then the number two on your telephone keypad. 00:00:36.020 -- 00:00:40.280 It is now my pleasure to turn the conference over to Lisa Wilson. 00:00:40.280 -- 00:00:42.700 Please go ahead. 00:00:42.700 -- 00:00:48.100 Thank you, operator. Welcome to ANI Pharmaceuticals Q2 2025 00:00:48.100 -- 00:00:53.760 Earnings Results Call. This is Lisa Wilson, Investor Relations for ANI. 00:00:53.760 -- 00:00:59.120 With me on today's call are Nikhil Lalwani, President and Chief Executive 00:00:59.120 -- 00:01:00.620 Officer, 00:01:00.620 -- 00:01:05.760 Steve Carey, Chief Financial Officer, Chris Mutz, Senior Vice President and 00:01:05.760 -- 00:01:09.480 Head of ANI's Rare Disease Business, and Dr. 00:01:09.480 -- 00:01:13.340 Mary Powell, our Chief Medical Officer. 00:01:13.340 -- 00:01:18.360 You can also access the webcast of this call through the Investor section 00:01:18.360 -- 00:01:22.260 of the ANI website at ANIPharmaceuticals.com. 00:01:22.700 -- 00:01:28.120 Before we get started, I would like to remind everyone that any statements made on today's 00:01:28.120 -- 00:01:33.380 conference call that express a belief, expectation,...